Acrobat Genomics Wins Golden Ticket Provided by Nitto Innovations

Nov 03, 2023

Acrobat Genomics wins a Golden Ticket provided by Nitto Innovations

Nitto Innovations and MBC BioLabs announce Acrobat Genomics as the winner of their 2023 Golden Ticket Competition. The award supports entrepreneurial scientists and emerging biotechnology start-ups to accelerate early drug discovery and innovation for the potential benefit of patients worldwide. More information on this program can be found here: MBC Biolabs Press Release

About Acrobat Genomics

Acrobat Genomics is a biotechnology startup focused on developing the next generation of genomic medicines. The company's proprietary platform technology allows for precise editing of disease-causing mutations, aiming to provide targeted therapies for those with limited treatment options. For more information, visit https://www.acrobatgenomics.com/.

About Nitto Innovations (NII)

Due to the increasing rate of technological innovation and globalization, product life-spans are getting shorter and manufacturers are required to diversify and speed up research and development projects. In order to make efficient use of the limited managerial resources under such circumstances, it is important that Nitto builds a system to search for and utilize technologies and businesses outside of the Nitto Group. Thus, Nitto established NII, which will operate and manage collaborations with startup companies. Located in Silicon Valley, where a large ecosystem of startup companies exists, NII and its experienced local staff, with the group-wide support of Nitto, is committed to external venture company growth and contributing to Nitto’s business.